Wockhardt gets FDA approval for cardiac drug
Pharmaceutical and biotechnology company Wockhardt Ltd said it received approval from the US Food and Drug Administration (USFDA) for marketing an extended-release tablets of Metoprolol succinate.
The drug is used for hypertension, treatment of angina and in improvement of survival after heart attack. Metoprolol succinate is the generic name for the brand Toprol XL, marketed in the US by Astra Zeneca. The product is being launched immediately.
On Friday, Wockhardt shares rose 3.8% to Rs145 on the Bombay Stock Exchange, while the Sensex closed 0.1% higher at 18,130 points.
July 30, 2010